Finance
How Ketamine Spawned a $1.7 Billion J&J Blockbuster Drug
Spravato, the ketamine-derived nasal spray from Johnson & Johnson, was once seen as a long shot. It was difficult to deliver, heavily regulated and slow to catch on. Find out how it became a billion-dollar drug and part of a new model for treating depression. (Source: Bloomberg)
B
Bloomberg
April 30, 2026·1 min read
Image: Bloomberg
Spravato, the ketamine-derived nasal spray from Johnson & Johnson, was once seen as a long shot. It was difficult to deliver, heavily regulated and slow to catch on. Find out how it became a billion-dollar drug and part of a new model for treating depression.
(Source: Bloomberg)
Original article
How Ketamine Spawned a $1.7 Billion J&J Blockbuster Drug
Published by Bloomberg